At a 1995 meeting, Purdue executives described how OxyContin could "cure" the "vulnerability" of generic Opposition and laid out how they prepared to sector the drug.Along with the reorganisation to be a "general public benefit" company, Purdue has proposed to settle the wider statements from it having a deal worthy of more than $10bn.Being an LAPD